跳至主要内容
临床试验/CTRI/2025/11/098096
CTRI/2025/11/098096尚未招募不适用

To assess the effect of preoperative oral carbohydrate electrolyte drink on postoperative insulin resistance in diabetic patients undergoing gastro-intestinal surgery : a randomized controlled study

Dr. swati singh1 个研究点 分布在 1 个国家目标入组 114 人开始时间: 2026年1月1日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
114
试验地点
1
主要终点
The primary outcome is insulin resistance assessed

研究概览

简要总结

Aim of this study is to investigate whether shortening the preoperative

fast using a solution containing carbohydrates can alter the acute-phase response

and clinical outcomes of elective major operations of the digestive tract by  assessing insulin resistance

by HOMA-IR on postoperative day 1 and also assessing Perioperative glycemia, length of stay, fasting blood glucose, fasting insulin,

insulin secretion index, insulin sensitivity index, intraoperative and post

operative blood glucose upto 24 h post-surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant, Investigator and Outcome Assessor Blinded

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • Patients having Diabetes Mellitus Type 2 undergoing elective gastric surgery, colorectal surgery (CRS) with FBS less than 200 mg/dl and HbA1c less than 7 will be included.
  • Expected postoperative hospital stay of more than 72 h.

排除标准

  • patients undergoing emergency surgery or secondary surgery
  • patients with inability to receive enteral nutrition
  • patients with comorbidities to ensure the safety of the trial and minimize the occurrence of adverse events
  • patients with mental disorders, alcohol addiction, or drug abuse history
  • lactating and pregnant women
  • patients with allergy to maltodextrin and various drugs.

结局指标

主要结局

The primary outcome is insulin resistance assessed

时间窗: 24 hour after surgery

by HOMA-IR on postoperative day 1.

时间窗: 24 hour after surgery

次要结局

  • The secondary outcomes will be(Perioperative glycemia, length of stay, fasting blood glucose, fasting insulin,)

研究者

发起方
Dr. swati singh
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Swati Singh

Indira gandhi institute of medical sciences, patna

研究点 (1)

Loading locations...

相似试验